MOSAIC IMMUNOENGINEERING, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
MOSAIC IMMUNOENGINEERING, INC. (CPMV) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.23 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-04-15
- MOSAIC IMMUNOENGINEERING, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-09-30 was 1.56M shares, a 51.70% decline year-over-year.
- MOSAIC IMMUNOENGINEERING, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-06-30 was 1.23M shares.
- MOSAIC IMMUNOENGINEERING, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-09-30 was 3.22M shares.
- MOSAIC IMMUNOENGINEERING, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-06-30 was 0.00 shares.
- MOSAIC IMMUNOENGINEERING, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 2.23M shares, a 8.77% decline from fiscal 2024.
- MOSAIC IMMUNOENGINEERING, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 2.44M shares, a 1.66% increase from fiscal 2023.
- MOSAIC IMMUNOENGINEERING, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 2.40M shares, a 7.30% increase from fiscal 2022.
- MOSAIC IMMUNOENGINEERING, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 2.24M shares, a 16.39% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 7 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | 2.23M shares 10-K · filed 2026-04-15 | ||||
| 2024-12-31 | 2.44M shares 10-K · filed 2026-04-15 | ||||
| 2023-12-31 | 2.40M shares 10-K · filed 2025-04-15 | ||||
| 2022-12-31 | 2.24M shares 10-K · filed 2024-04-15 | ||||
| 2021-12-31 | 1.92M shares 10-K · filed 2023-03-02 | ||||
| 2021-09-30 | 1.56M shares 10-Q · filed 2021-11-02 | 1.38M shares 10-Q · filed 2021-11-02 | |||
| 2021-06-30 | 1.23M shares 10-Q · filed 2021-08-03 | 1.18M shares 10-Q · filed 2021-08-03 | |||
| 2020-12-31 | 4.48M shares 10-K · filed 2022-01-26 | ||||
| 2020-09-30 | 3.22M shares 10-Q · filed 2021-11-02 | 1.60M shares 10-Q · filed 2021-11-02 | |||
| 2020-06-30 | 0.00 shares 10-Q · filed 2021-08-03 | ||||
| 2017-05-31 | 2.60M shares 10-K · filed 2017-08-29 | ||||
| 2016-05-31 | 2.76M shares 10-K · filed 2017-08-29 | ||||
| 2015-05-31 | 3.33M shares 10-K · filed 2016-08-29 | ||||
| 2013-02-28 | 825.00K shares 10-Q · filed 2013-04-15 | 825.00K shares 10-Q · filed 2013-04-15 | |||
| 2012-11-30 | 825.00K shares 10-Q · filed 2013-01-14 | 825.00K shares 10-Q · filed 2013-01-14 | |||
| 2012-08-31 | 1.57M shares 10-Q · filed 2012-10-15 | ||||
| 2012-02-29 | 2.45M shares 10-Q · filed 2013-04-15 | 2.45M shares 10-Q · filed 2013-04-15 | |||
| 2011-11-30 | 2.90M shares 10-Q · filed 2013-01-14 | 2.90M shares 10-Q · filed 2013-01-14 | |||
| 2011-08-31 | 3.01M shares 10-Q · filed 2012-10-15 |